127 related articles for article (PubMed ID: 37944060)
1. Clinician Perspectives Regarding the Impact of Information Technology on Multidisciplinary Tumor Boards: A National Comprehensive Cancer Network Survey.
Arafat W; Fu P; Wagner AJ; Osterman T; Martin DB; Sugalski J; Heinrichs T; Racz J; Tevaarwerk AJ
JCO Clin Cancer Inform; 2023 Sep; 7():e2300056. PubMed ID: 37944060
[TBL] [Abstract][Full Text] [Related]
2. Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
Ciliberto G; Canfora M; Terrenato I; Agnoletto C; Agustoni F; Amoroso L; Baldassarre G; Curigliano G; Delmonte A; De Luca A; Fiorentino M; Gregorc V; Ibrahim T; Lazzari C; Mastronuzzi A; Pronzato P; Santoro A; Scambia G; Tommasi S; Vingiani A; Giacomini P; De Maria R
J Exp Clin Cancer Res; 2022 Oct; 41(1):305. PubMed ID: 36245005
[TBL] [Abstract][Full Text] [Related]
3. Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey.
Tevaarwerk AJ; Chandereng T; Osterman T; Arafat W; Smerage J; Polubriaginof FCG; Heinrichs T; Sugalski J; Martin DB
JCO Oncol Pract; 2021 Sep; 17(9):e1318-e1326. PubMed ID: 34264741
[TBL] [Abstract][Full Text] [Related]
4. Involvement of radiologists in oncologic multidisciplinary team meetings: an international survey by the European Society of Oncologic Imaging.
Neri E; Gabelloni M; Bäuerle T; Beets-Tan R; Caruso D; D'Anastasi M; Dinkel J; Fournier LS; Gourtsoyianni S; Hoffmann RT; Mayerhöfer ME; Regge D; Schlemmer HP; Laghi A
Eur Radiol; 2021 Feb; 31(2):983-991. PubMed ID: 32833089
[TBL] [Abstract][Full Text] [Related]
5. Implementing multidisciplinary tumor boards in oncology: a narrative review.
Mano MS; Çitaku FT; Barach P
Future Oncol; 2022 Jan; 18(3):375-384. PubMed ID: 34787482
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
Koopman B; Groen HJM; Ligtenberg MJL; Grünberg K; Monkhorst K; de Langen AJ; Boelens MC; Paats MS; von der Thüsen JH; Dinjens WNM; Solleveld N; van Wezel T; Gelderblom H; Hendriks LE; Speel EM; Theunissen TE; Kroeze LI; Mehra N; Piet B; van der Wekken AJ; Ter Elst A; Timens W; Willems SM; Meijers RWJ; de Leng WWJ; van Lindert ASR; Radonic T; Hashemi SMS; Heideman DAM; Schuuring E; van Kempen LC
Oncologist; 2021 Aug; 26(8):e1347-e1358. PubMed ID: 33111480
[TBL] [Abstract][Full Text] [Related]
7. Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals.
Fasola G; Barducci MC; Pelizzari G; Grossi F; Pinto C; Daniele B; Giordano M; Ortega C; Silva RR; Tozzi VD; Cavanna L; Aprile G
Oncologist; 2023 Jun; 28(6):e324-e330. PubMed ID: 36848261
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures.
Engelhardt M; Ihorst G; Schumacher M; Rassner M; Gengenbach L; Möller M; Shoumariyeh K; Neubauer J; Farthmann J; Herget G; Wäsch R
BMC Cancer; 2021 Feb; 21(1):173. PubMed ID: 33596881
[TBL] [Abstract][Full Text] [Related]
9. Molecular Tumor Boards: current practice and future needs.
van der Velden DL; van Herpen CML; van Laarhoven HWM; Smit EF; Groen HJM; Willems SM; Nederlof PM; Langenberg MHG; Cuppen E; Sleijfer S; Steeghs N; Voest EE
Ann Oncol; 2017 Dec; 28(12):3070-3075. PubMed ID: 29045504
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Electronic Health Record Use on Physician Burnout: Cross-Sectional Survey.
Tajirian T; Stergiopoulos V; Strudwick G; Sequeira L; Sanches M; Kemp J; Ramamoorthi K; Zhang T; Jankowicz D
J Med Internet Res; 2020 Jul; 22(7):e19274. PubMed ID: 32673234
[TBL] [Abstract][Full Text] [Related]
11. Practice and Impact of Multidisciplinary Tumor Boards on Patient Management: A Prospective Study.
Charara RN; Kreidieh FY; Farhat RA; Al-Feghali KA; Khoury KE; Haydar A; Nassar L; Berjawi G; Shamseddine A; El Saghir NS
J Glob Oncol; 2017 Jun; 3(3):242-249. PubMed ID: 28717766
[TBL] [Abstract][Full Text] [Related]
12. Adoption of Patient-Generated Health Data in Oncology: A Report From the NCCN EHR Oncology Advisory Group.
Stetson PD; McCleary NJ; Osterman T; Ramchandran K; Tevaarwerk A; Wong T; Sugalski JM; Akerley W; Mercurio A; Zachariah FJ; Yamzon J; Stillman RC; Gabriel PE; Heinrichs T; Kerrigan K; Patel SB; Gilbert SM; Weiss E
J Natl Compr Canc Netw; 2022 Jan; 20(13):. PubMed ID: 35042190
[TBL] [Abstract][Full Text] [Related]
13. Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer.
Gebbia V; Guarini A; Piazza D; Bertani A; Spada M; Verderame F; Sergi C; Potenza E; Fazio I; Blasi L; La Sala A; Mortillaro G; Roz E; Marchese R; Chiarenza M; Soto-Parra H; Valerio MR; Agneta G; Amato C; Lipari H; Baldari S; Ferraù F; Di Grazia A; Mancuso G; Rizzo S; Firenze A
Pulm Ther; 2021 Dec; 7(2):295-308. PubMed ID: 34089169
[TBL] [Abstract][Full Text] [Related]
14. Attitudes and Perceptions of Multidisciplinary Cancer Care Clinicians Toward Telehealth and Secure Messages.
Neeman E; Kumar D; Lyon L; Kolevska T; Reed M; Sundaresan T; Arora A; Li Y; Seaward S; Kuehner G; Likely S; Trosman J; Weldon C; Liu R
JAMA Netw Open; 2021 Nov; 4(11):e2133877. PubMed ID: 34817586
[TBL] [Abstract][Full Text] [Related]
15. Usability problems do not heal by themselves: National survey on physicians' experiences with EHRs in Finland.
Kaipio J; Lääveri T; Hyppönen H; Vainiomäki S; Reponen J; Kushniruk A; Borycki E; Vänskä J
Int J Med Inform; 2017 Jan; 97():266-281. PubMed ID: 27919385
[TBL] [Abstract][Full Text] [Related]
16. Regionalization of Head and Neck Oncology Tumor Boards: Perspectives of Collaborating Physicians.
Amin NB; Bridgham KM; Brown JP; Moyer KF; Taylor RJ; Wolf JS; Witek ME; Molitoris JK; Mehra R; Cullen KJ; Papadimitriou JC; Raghavan P; Hatten KM
OTO Open; 2023; 7(1):e18. PubMed ID: 36998543
[TBL] [Abstract][Full Text] [Related]
17. Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center.
Jain NM; Schmalz L; Cann C; Holland A; Osterman T; Lang K; Wiesner GL; Pal T; Lovly C; Stricker T; Micheel C; Balko JM; Johnson DB; Park BH; Iams W
Oncologist; 2021 Nov; 26(11):e1962-e1970. PubMed ID: 34390291
[TBL] [Abstract][Full Text] [Related]
18. Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.
Naito Y; Sunami K; Kage H; Komine K; Amano T; Imai M; Koyama T; Ennishi D; Kanai M; Kenmotsu H; Maeda T; Morita S; Sakai D; Watanabe K; Shirota H; Kinoshita I; Yoshioka M; Mamesaya N; Ito M; Kohsaka S; Saigusa Y; Yamamoto K; Hirata M; Tsuchihara K; Yoshino T
JAMA Netw Open; 2022 Dec; 5(12):e2245081. PubMed ID: 36469316
[TBL] [Abstract][Full Text] [Related]
19. Quality of leadership in multidisciplinary cancer tumor boards: development and evaluation of a leadership assessment instrument (ATLAS).
Jalil R; Soukup T; Akhter W; Sevdalis N; Green JSA
World J Urol; 2018 Jul; 36(7):1031-1038. PubMed ID: 29502300
[TBL] [Abstract][Full Text] [Related]
20. Decision-Making in Multidisciplinary Tumor Boards in Breast Cancer Care - An Observational Study.
Schellenberger B; Diekmann A; Heuser C; Gambashidze N; Ernstmann N; Ansmann L
J Multidiscip Healthc; 2021; 14():1275-1284. PubMed ID: 34103928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
